Speed The Publishing Process

A longtime reader and periodic contributor to a "fast-track" journal the past 21 years and an editorial board member thereof the past nine years, I read with considerable interest the article "Journals Feel Pressure To Speed The Publishing Process" (R. Lewis, The Scientist, Sept. 19, 1994, page 21), but found no mention of the journal Medical Science Research (MSR). Launched in 1973 by ier Science Publishers (Amsterdam), initially under the title IRCS Medical Science and currently published by

Written byRichard Ablin
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Launched in 1973 by ier Science Publishers (Amsterdam), initially under the title IRCS Medical Science and currently published by Chapman and Hall (London), MSR is unique in publishing short basic and clinical research communications, together with editorials, review articles focusing on emerging "hot spots" in research, letters to the editor, and occasional speculative essays across the entire spectrum of medical sciences very quickly--within an average of four weeks of acceptance.

MSR is led by editor Bernard Dixon, and supported by a distinguished international editorial advisory board, which includes Roy Y. Calne and David Horrobin; the late Linus Pauling was also a member. Every contribution is externally peer-refereed. It is abstracted and indexed in, among others, Biological Abstracts, Chemical Abstracts, Current Contents/Life Sciences, and Excerpta Medica. Important recent papers have included the first report of the immunosuppressive action of rapamycin, preceded some 10 years earlier also by the first report, in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies